Cost-Effectiveness of Eradication ofHelicobacter pyloriin Gastric Cancer Survivors After Endoscopic Resection of Early Gastric Cancer
- 1 December 2009
- journal article
- Published by Wiley in Helicobacter
- Vol. 14 (6), 536-544
- https://doi.org/10.1111/j.1523-5378.2009.00721.x
Abstract
Clinical effectiveness of Helicobacter pylori eradication in gastric cancer survivors after endoscopic resection of early gastric cancer (EGC) was recently established in a randomized controlled trial. We aimed to establish long-term cost-effectiveness in gastric cancer survivors after endoscopic resection of EGC. A Markov model was constructed to compare the costs and outcomes of the two intervention strategies: (1) eradicate H. pylori after complete resection of EGC by endoscopy (2) do not eradicate. Estimates for variables in the model were obtained by extensive review of published reports. Analyses were made from the Korean public healthcare provider's perspective. Base-case analysis indicated H. pylori eradication costs less (US$ 29,780 vs. US$ 30,594) than no eradication, and save more lives (mean life expectancy from eradication: 13.60 years vs. 13.55 years). One-way and three-way sensitivity analyses showed the robustness of the cost-effectiveness results. In this selective population with very high risk of developing gastric cancer, H. pylori eradication should be considered for reimbursement with priority to prevent subsequent cancer and also reduce health care cost.Keywords
This publication has 35 references indexed in Scilit:
- Cancer Control Activities in the Republic of KoreaJapanese Journal of Clinical Oncology, 2008
- Asia–Pacific consensus guidelines on gastric cancer preventionJournal of Gastroenterology and Hepatology, 2008
- National Cancer Incidence for the Year 2002 in KoreaCancer Research and Treatment, 2007
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbilsThe Esophagus, 2005
- Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trialsThe Lancet, 1996
- Helicobacter pyloriInfection and Gastric Carcinoma among Japanese Americans in HawaiiNew England Journal of Medicine, 1991
- Helicobacter pyloriInfection and the Risk of Gastric CarcinomaNew England Journal of Medicine, 1991
- Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.BMJ, 1991